Europe to review safety data for Eisai-Biogen Alzheimer's drug
The European Commission has requested its medicines regulator to consider safety information on Eisai and Biogen's ...
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...
Voyager: Crossing The Blood-Brain Barrier, Competitors, And Investment Relevance
Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...
Le Lézard18m
VANTAGE FOUNDATION PARTNERS WITH SOS CHILDREN'S VILLAGES PHILIPPINES TO EMPOWER VULNERABLE CHILDREN AND FAMILIES
Vantage Foundation proudly announces its partnership with SOS Children's Villages Philippines, a NGO committed to providing ...
Le Lézard8m
REPLY: Coding and Cybersecurity, Registration Is Now Open for the Reply Hack The Code Challenge 2025
Reply has announced the opening of registrations for the Reply Hack The Code Challenge 2025, the leading online team coding competition, which will take place on March 12th 2025. This year's challenge ...
American Association of Individual Investors18h
Which Is a Better Investment, Biogen Inc. or Natera, Inc. Stock?
Learn more about whether Biogen Inc. or Natera, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Mint14h
Biogen Pharmachem Industries share price
Biogen Pharmachem Industries Limited is an India-based company, which is not engaged in any activity. The Company is looking for the right opportunity to make the Company operational. What is the ...